BioSpace Global Roundup, Oct. 15
The Pharma Data
OCTOBER 14, 2020
Lanifibranor is believed to be the first drug candidate to be granted this status for the treatment of NASH since January 2015. Talking Medicine uses advanced AI to provide pharmaceutical companies with real-time data intelligence. Axol Bioscience – Based in the U.K., Dolmatics – U.K.-based based Dotmatics Ltd.
52 
Let's personalize your content